From our analysis of 39 neighboring proteins of genetic risk factors in the cytokine signaling pathway, these findings suggest TNFRSF1A, IL1R1, and IL6ST are promising therapeutic targets and biomarkers for developing therapies and diagnostics for RA and related inflammatory diseases. This evidence concerns the gene IL6ST and rheumatoid arthritis.